Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on September 3, 2026

Sep. 3, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism

Indeterminate GlobeNewswire

Sep. 3, 2026

L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.

Indeterminate GlobeNewswire

Sep. 3, 2026

LB Pharmaceuticals to Participate in Upcoming September Investor Events

Indeterminate GlobeNewswire

Sep. 3, 2026

Agomab to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

CapsoVision to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Immuneering to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Sep. 3, 2026

Spyre Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Lifecore Biomedical to Participate at CPHI Global Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data

Indeterminate GlobeNewswire

Sep. 3, 2026

Alector to Participate in Upcoming Healthcare Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire